Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rumen-derived Prevotella and Megasphaera elsdenii mitigate methane production through functional modulation of rumen microbial metabolism.

Journal of animal science and biotechnology·2026

Same author

Fermented palm kernel cake improves the nutrient degradation of beef cattle by modulating the rumen microbiota.

Frontiers in microbiology·2025

Same author

Functional role of <i>FvMdm10</i> in stress response, pathogenicity, and fumonisins production in <i>fusarium verticillioides</i>.

Virulence·2025

Same author

Unlocking Gut Health: The Potent Role of Stilbenoids in Intestinal Homeostasis.

Animals : an open access journal from MDPI·2025

Same author

Nutritional Value Evaluation and Processing Technology of Feed and Nutrition Regulation Measures for Ruminants.

Animals : an open access journal from MDPI·2024

Same author

Licorice Extract Supplementation Benefits Growth Performance, Blood Biochemistry and Hormones, Immune Antioxidant Status, Hindgut Fecal Microbial Community, and Metabolism in Beef Cattle.

Veterinary sciences·2024

Search research articles

Related Experiment Video

Updated: Sep 19, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Probiotics and triglyceride manipulation: potential implications for alleviating hypertriglyceridemia.

Mingliang Zhang¹, Weimin Jiang², Jie Yin¹

¹College of Animal Science and Technology, Hunan Agriculture University, Changsha 410128, China; Yuelushan Laboratory, Changsha 410128, China.

Journal of Advanced Research

|June 18, 2025

Summary

Probiotic interventions show promise in managing hypertriglyceridemia by influencing gut microbiota and host lipid metabolism. Further research into next-generation probiotics could offer new therapeutic strategies for this common lipid abnormality.

Keywords:

Gut microbiota Hypertriglyceridemia Lowering triglycerides Next-generation probiotics

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Sep 19, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Area of Science:

Microbiology
Metabolic Disorders
Gastroenterology

Background:

Hypertriglyceridemia is a common lipid disorder, often resulting from genetic and environmental factors.
Secondary causes include obesity, diabetes, alcohol, diet, and certain medications.
Gut microbiota modulation via probiotics is a potential strategy to lower triglyceride levels.

Purpose of the Study:

Review animal and human studies on probiotic interventions for hypertriglyceridemia.
Summarize mechanisms by which probiotics reduce triglyceride levels.
Explore the potential of next-generation probiotics.

Main Methods:

Literature review of recent animal and human studies.
Analysis of mechanisms involving gut microbiota, short-chain fatty acids, and bile acids.
Discussion of challenges and prospects for probiotic application.

Main Results:

Probiotics can impact intestinal lipid absorption and host lipid metabolism.
Specific probiotic mechanisms involve metabolites like short-chain fatty acids and bile acids.
Next-generation probiotics may offer enhanced therapeutic benefits.

Conclusions:

Gut microbiota plays a significant role in hypertriglyceridemia.
Probiotics, particularly next-generation strains, represent a promising avenue for managing hypertriglyceridemia.
Further research is needed to overcome challenges and realize the full potential of probiotics.